CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Trends Analyst Outlook Journalist POV

40 hedge funds and large institutions have $947M invested in Centessa Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more funds holding in top 10

Funds holding in top 10: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

20% less funds holding

Funds holding: 50 → 40 (-10)

63% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 16

Holders
40
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$137M
2
+$38.4M
3
+$12.1M
4
BC
Boxer Capital
California
+$7.18M
5
CAM
Cormorant Asset Management
Massachusetts
+$4.99M

Top Sellers

1
-$24.6M
2
-$11.1M
3
-$7.14M
4
Millennium Management
Millennium Management
New York
-$3.53M
5
MIM
Monashee Investment Management
Massachusetts
-$2.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$555K
27
$447K
28
$251K
29
$207K
30
$128K
31
$46K
32
$46K
33
$30K
34
$8K
35
$4K
36
$3K
37
$3K
38
$3K
39
$2K
40
–
41
–
42
–
43
–
44
–
45
–
46
–
47
–
48
–
49
–
50
–
1
2
3